HIMS Intrinsic Value Calculator – HIMS & HERS HEALTH Reports Second Quarter Financial Results for Fiscal Year 2023
August 19, 2023
🌥️Earnings Overview
HIMS & HERS HEALTH ($NYSE:HIMS) reported total revenue of USD 207.9 million for the second quarter of its fiscal year 2023, which ended June 30, 2023; showing a year-over-year growth of 83.1%. Net income, however, decreased from -19.7 million in the same quarter of the prior year to -7.2 million.
Market Price
At the start of the day, the company’s stock opened at $8.3 and closed at $7.9, representing a decrease of 3.1% from the previous closing price of 8.2. HIMS & HERS HEALTH continue to invest in its technology platform offerings and launch new products in order to better serve its customer base. The company is also focused on improving patient outcomes and expanding its network of providers to make its services more accessible. The company’s management expressed confidence in its long-term growth prospects, citing the strong financial performance in the second quarter as evidence of the success of their strategic initiatives. As HIMS & HERS HEALTH continues to strive towards its goals, investors remain optimistic about the future of the company. Live Quote…
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for HIMS. More…
| Total Revenues | Net Income | Net Margin |
| 710.72 | -46.97 | -6.6% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for HIMS. More…
| Operations | Investing | Financing |
| 25.57 | 1.69 | -16.91 |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for HIMS. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 389.88 | 69.81 | 1.53 |
Key Ratios Snapshot
Some of the financial key ratios for HIMS are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| 85.5% | – | -7.3% |
| FCF Margin | ROE | ROA |
| 1.6% | -10.3% | -8.3% |
Analysis – HIMS Intrinsic Value Calculator
At GoodWhale, we have analyzed the wellbeing of HIMS & HERS HEALTH. Our proprietary Valuation Line has estimated the fair value of the stock to be around $21.9. However, the actual stock price is currently at $7.9 – which implies that the stock is undervalued by 63.9%. This makes it a genuine opportunity to invest in the company at an attractive price. More…
Peers
Hims & Hers Health Inc is a company that provides health and beauty products. The company has a wide range of products that includes health supplements, skincare products, and makeup products. The company operates in the United States, Canada, and the United Kingdom. The company has a strong online presence and offers its products through its website and online stores. The company has a team of experts who research and develop new products. The company has a wide range of products that are popular among its customers. The company’s products are available at a reasonable price and are of high quality.
– Yoshitsu Co Ltd ($NASDAQ:TKLF)
Yoshitsu Co Ltd is a Japanese company with a market cap of 45.68M as of 2022. The company has a Return on Equity of 14.38%. Yoshitsu Co Ltd is engaged in the manufacture and sale of textile products. The company’s products include fabrics, garments, and home furnishings.
– The Beauty Health Co ($NASDAQ:SKIN)
The Beauty Health Co has a market cap of 1.91B as of 2022, a Return on Equity of -30.91%. The company operates in the health and beauty industry, with a focus on providing products and services that improve the lives of its customers. The company’s products and services are designed to make people look and feel their best, and its commitment to customer satisfaction is evident in its strong market share and loyal customer base.
– CI Medical Co Ltd ($TSE:3540)
Founded in 1995, CIC Medical Co Ltd is a leading provider of medical devices and services. The company has a market cap of 49.3B as of 2022 and a return on equity of 15.93%. CIC Medical Co Ltd provides a wide range of medical devices and services, including diagnostic imaging, medical equipment, and services for the treatment of cancer and other diseases. The company has a strong presence in China, with over 1,000 hospitals and clinics using its products and services. CIC Medical Co Ltd is committed to providing quality products and services to its customers and to improving the lives of patients around the world.
Summary
HIMS & HERS HEALTH reported their financial results for the second quarter of fiscal year 2023, showing an impressive year-over-year revenue growth of 83.1%. Despite the increase in revenue, the company saw a net income decrease from -19.7 million to -7.2 million. This led to a drop in their stock price on the same day.
From an investing standpoint, HIMS & HERS HEALTH presents investors with both short-term and long-term opportunities, depending on whether they are willing to take on additional risk. While the company has seen increased revenue growth, the decreased net income could be cause for concern as investors weigh their options.
Related Posts
Recent Posts
